An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
Intravesical Bacillus Calmette-Guerin (BCG) is approved for non-muscle invasive bladder cancer treatment a long time ago. Chimeric antigen receptor T cells (CAR-Tcell), are T cells are genetically engineered T cells that produce an artificial T-cell receptor for use in immunotherapy. Chimeric antige...
Guardado en:
Autores principales: | Seyed Saeed Tamehri Zadeh, AhmadReza Rezaeian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Urology Research Center
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a53ef52572b4e01b9c5a4e99fb990af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Hongda Zhao, et al.
Publicado: (2021) -
Espondilodiscitis con absceso intrarraquídeo y paraespinal causada por bacilo de Calmette-Guérin (BCG)
por: Lara-Oya,Ana, et al.
Publicado: (2015) -
A review on the evolution of immunotherapy in bladder carcinoma
por: Milena Gulinac, et al.
Publicado: (2020) -
Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021) -
Infección diseminada por BCG en la Región de Los Lagos, Chile: Reporte de cinco casos clínicos
por: STRICKLER P,ALEXIS, et al.
Publicado: (2009)